Nick Andrews

38.3k total citations · 8 hit papers
401 papers, 19.5k citations indexed

About

Nick Andrews is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Nick Andrews has authored 401 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Epidemiology, 110 papers in Microbiology and 102 papers in Infectious Diseases. Recurrent topics in Nick Andrews's work include Pneumonia and Respiratory Infections (126 papers), Influenza Virus Research Studies (116 papers) and Bacterial Infections and Vaccines (109 papers). Nick Andrews is often cited by papers focused on Pneumonia and Respiratory Infections (126 papers), Influenza Virus Research Studies (116 papers) and Bacterial Infections and Vaccines (109 papers). Nick Andrews collaborates with scholars based in United Kingdom, United States and Maldives. Nick Andrews's co-authors include Elizabeth Miller, Mary Ramsay, Julia Stowe, Ray Borrow, Maria Zambon, Shamez Ladhani, Gayatri Amirthalingam, David Goldblatt, Jamie Lopez Bernal and Helen Campbell and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Nick Andrews

386 papers receiving 18.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

2021 1.7k citations Jamie Lopez Bernal, Nick Andrews et al. profile →
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

2021 744 citations Jamie Lopez Bernal, Nick Andrews et al. profile →
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

2010 577 citations Elizabeth Miller, Katja Höschler et al. profile →
Effectiveness of maternal pertussis vaccination in England: an observational study

2014 529 citations Gayatri Amirthalingam, Nick Andrews et al. profile →
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

2014 393 citations Nick Andrews, Shamez Ladhani et al. The Lancet Infectious Diseases profile →
Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis

2022 141 citations Elizabeth Miller, Nick Andrews et al. The Lancet Infectious Diseases profile →
Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational study

2023 87 citations Nick Andrews, Shamez Ladhani et al. The Lancet Infectious Diseases profile →
Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study

2024 49 citations Nick Andrews, Mary Ramsay et al. The Lancet Infectious Diseases profile →

Peers

Countries citing papers authored by Nick Andrews

Since Specialization

Citations

This map shows the geographic impact of Nick Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Andrews more than expected).

Fields of papers citing papers by Nick Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Andrews. The network helps show where Nick Andrews may publish in the future.

Co-authorship network of co-authors of Nick Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Andrews. A scholar is included among the top collaborators of Nick Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Andrews. Nick Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying markers of health-seeking behaviour and healthcare access in UK electronic health records 2024 ·BMJ Open ·Sophie Graham, Jemma Walker, Nick Andrews, Dorothea Nitsch, Edward P K Parker, Helen McDonald	1
2	Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study 2024 ·NIHR Open Research ·Jonathan Broad, Dominic Sparkes, Naomi Platt, Anna Howells, Sarah Foulkes, Jameel Khawam, Michelle Cole, Nick Andrews, Conall Watson, Susan Hopkins, Victoria Hall, (unknown)	1
3	Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients 2024 ·Vaccine ·Heather Whitaker, (unknown), Katja Höschler, (unknown), Julia Stowe, Nicki L. Boddington, (unknown), Hongxin Zhao, Ezra Linley, (unknown), Cecilia Okusi, (unknown), Rachel Byford, Simon de Lusignan, Gayatri Amirthalingam, Maria Zambon, Nick Andrews, Conall Watson	3
4	Vaccine effectiveness against mild and severe covid-19 in pregnant individuals and their infants in England: test negative case-control study 2024 ·SHILAP Revista de lepidopterología ·Freja Kirsebom, Nick Andrews, Anna Mensah, Julia Stowe, Shamez Ladhani, Mary Ramsay, Jamie Lopez Bernal, Helen Campbell	2
5	Effectiveness of the Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation in England 2024 ·EClinicalMedicine ·Freja Kirsebom, Nick Andrews, Julia Stowe, Gavin Dabrera, Mary Ramsay, Jamie Lopez Bernal	6
6	Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study 2023 ·The Lancet Infectious Diseases ·Freja Kirsebom, Nick Andrews, Julia Stowe, Mary Ramsay, Jamie Lopez Bernal	32
7	The impact of vaccination and SARS-CoV-2 variants on the virological response to SARS-CoV-2 infections during the Alpha, Delta, and Omicron waves in England 2023 ·Journal of Infection ·(unknown), Catherine Quinot, Freja Kirsebom, Nick Andrews, (unknown), Louise Letley, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Samreen Ijaz, Maria Zambon, Kevin Brown, Mary Ramsay, Jamie Lopez Bernal	8
8	Optimal age targeting for pneumococcal vaccination in older adults; a modelling study 2023 ·Nature Communications ·Deus Thindwa, Samuel Clifford, Jackie Kleynhans, Anne von Gottberg, Sibongile Walaza, Susan Meiring, Todd D. Swarthout, Elizabeth Miller, Peter McIntyre, Nick Andrews, Zahin Amin‐Chowdhury, Norman K. Fry, Kondwani Jambo, Neil French, Samanta Cristine Grassi Almeida, Shamez Ladhani, Robert S. Heyderman, Cheryl Cohen, Maria Cristina de Cunto Brandileone, Stefan Flasche	7
9	Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking 2023 ·Nature Communications ·Sophie Graham, Elise Tessier, Julia Stowe, Jamie Lopez Bernal, Edward P K Parker, Dorothea Nitsch, (unknown), Nick Andrews, Jemma Walker, Helen McDonald	3
10	Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16 2022 ·Influenza and Other Respiratory Viruses ·Nicki L. Boddington, Punam Mangtani, Hongxin Zhao, Neville Q. Verlander, Joanna Ellis, Nick Andrews, Richard Pebody	8
11	Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages 2022 ·The Journal of Infectious Diseases ·Tommy Nyberg, Katie Harman, Asad Zaidi, Shaun R. Seaman, Nick Andrews, Sophie Nash, André Charlett, Jamie Lopez Bernal, Richard Myers, Natalie Groves, Eileen Gallagher, Saheer E. Gharbia, Meera Chand, Simon Thelwall, Daniela De Angelis, Gavin Dabrera, Anne M. Presanis	6
12	Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England 2022 ·Nature Communications ·Freja Kirsebom, Nick Andrews, (unknown), Julia Stowe, Mary Ramsay, Jamie Lopez Bernal	27
13	Disease severity during SARS-COV-2 reinfection: a nationwide study 2022 ·Journal of Infection ·Anna Mensah, Joanne Lacy, Julia Stowe, (unknown), (unknown), Ruth Simmons, Antoaneta Bukasa, Shennae O’Boyle, Nick Andrews, Mary Ramsay, Helen Campbell, Kevin Brown	52
14	Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study 2022 ·Nature Communications ·Julia Stowe, Nick Andrews, Freja Kirsebom, Mary Ramsay, Jamie Lopez Bernal	85
15	Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017 2021 ·Influenza and Other Respiratory Viruses ·Mary Sinnathamby, Fiona Warburton, Nick Andrews, Nicki L. Boddington, Hongxin Zhao, Joanna Ellis, Elise Tessier, Matthew Donati, Alex J. Elliot, Helen E. Hughes, Rachel Byford, Gillian Smith, Manasa Tripathy, Simon de Lusignan, Maria Zambon, Richard Pebody	6
16	Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design 2021 ·International Journal of Epidemiology ·Julia Stowe, Elise Tessier, Hongxin Zhao, Rebecca Guy, Berit Müller‐Pebody, Maria Zambon, Nick Andrews, Mary Ramsay, Jamie Lopez Bernal	154
17	Impact analysis of rotavirus vaccination in various geographic regions in Western Europe 2021 ·Vaccine ·Janneke D. M. Verberk, (unknown), Jan van de Kassteele, Nick Andrews, Rolina D. van Gaalen, Susan Hahné, Harry Vennema, Mary Ramsay, Tessa Braeckman, Shamez Ladhani, Samantha Thomas, Jemma Walker, Hester E. de Melker, Thea Kølsen Fischer, Judith Koch, Patricia Bruijning‐Verhagen	8
18	Blood donation by men who have sex with men: using evidence to change policy 2021 ·Vox Sanguinis ·Katy Davison, Claire Reynolds, Nick Andrews, Susan R. Brailsford, (unknown)	17
19	Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis 2021 ·Vaccine ·Frank Sandmann, Mark Jit, Nick Andrews, Hannah Buckley, Helen Campbell, Sonia Ribeiro, (unknown), Julia Stowe, Elise Tessier, Mary Ramsay, Gayatri Amirthalingam, Yoon Hong Choi	5
20	Immune response to pneumococcal conjugate vaccination in asplenic individuals 2009 ·Human Vaccines ·Elaine Stanford, (unknown), (unknown), Kenneth Lamden, (unknown), Nick Phin, David Baxter, MATTHEW HELBERT, Rosemary McCann, Nick Andrews, Paul Balmer, Ray Borrow, Edward B. Kaczmarski	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact